Skip to content
October 18, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Patient Advocacy and Support
  • Navigating the “New Normal”: Breast Cancer Canada Announces Comprehensive Survivorship Webinar Series for 2026
  • Patient Advocacy and Support

Navigating the “New Normal”: Breast Cancer Canada Announces Comprehensive Survivorship Webinar Series for 2026

Nana October 17, 2026 8 minutes read
navigating-the-new-normal-breast-cancer-canada-announces-comprehensive-survivorship-webinar-series-for-2026

TORONTO, ON – As the medical community continues to make strides in early detection and acute treatment for breast cancer, a critical gap remains in the long-term support for survivors transitioning out of clinical care. Addressing this "missing chapter" of the patient journey, Breast Cancer Canada has announced a landmark two-part webinar series for October 2026. Titled "Living Well" and "Moving Emotions Forward," the series aims to provide survivors with the tools necessary to navigate the complex physical and psychological landscapes that persist long after the final round of chemotherapy or radiation.

The initiative comes at a pivotal time when survivorship rates are at an all-time high, yet many patients report feeling "dropped off a cliff" once their active treatment protocols conclude. By bringing together industry experts, advocates, and survivors, the series seeks to redefine post-treatment care as an essential component of the oncological continuum.

Main Facts: Addressing the Holistic Needs of Survivors

The 2026 webinar series is structured into two distinct but interconnected sessions, each focusing on a different pillar of recovery: the physical body and the emotional psyche.

Session I: Physicality and Rehabilitation

The first session, scheduled for October 15, 2026, titled "Living Well: Physical Effects Beyond Breast Cancer Treatment," features Voula Pantelis, a prominent breast cancer advocate and the General Manager of AMOENA Canada. This session focuses on the "unseen" physical toll of cancer. While surgery may remove the tumor, the legacy of that surgery—ranging from scar tissue adhesions to lymphedema—can affect a woman’s quality of life for decades.

Pantelis will address the practicalities of post-surgical life, including:

  • Scar Management: Techniques to improve tissue elasticity and reduce discomfort.
  • Lymphedema Prevention and Care: Managing the chronic swelling that often follows lymph node removal.
  • Compression and Prosthetics: The role of specialized garments in restoring body symmetry and confidence.
  • Travel and Activity: Practical advice for survivors reclaiming their active lifestyles, including how to manage physical limitations during air travel.

Session II: Emotional Resilience and Identity

The second session, occurring on October 22, 2026, titled "Moving Emotions Forward: Root to Rise," is led by Jacqueline Beatty, a breast cancer survivor and the founder of Rising Lotus. This segment pivots toward the internal experience of survivorship. Beatty’s "Root to Rise" framework is designed to help survivors process the trauma of diagnosis and the disorientation of the "post-cancer" identity.

Key themes include:

  • The Identity Crisis: Navigating the shift from "patient" back to "person."
  • Emotional Regulation: Managing the "scanxiety" and fear of recurrence that often haunts survivors.
  • Professional Reintegration: The complexities of returning to the workforce after a significant health hiatus.
  • Relationship Dynamics: How boundaries and priorities shift within families and social circles following a life-threatening illness.

Chronology of the Survivorship Movement

The evolution of breast cancer care has moved through several distinct eras, leading to the necessity of the upcoming 2026 series.

1. The Era of Eradication (1970s–1990s): During this period, the primary focus of the medical community was survival at any cost. Radical surgeries and aggressive systemic treatments were the norms. The "success" of a treatment was measured solely by five-year survival rates, with little regard for the long-term physical or mental fallout.

2. The Rise of Awareness (2000s–2010s): This era saw the explosion of the "Pink Ribbon" movement. Funding for research increased exponentially, and early detection through mammography became a public health priority. However, the narrative remained largely focused on the "battle" and the "cure," often overlooking the chronic nature of post-treatment life.

3. The Survivorship Revolution (2020–Present): Today, there is a growing recognition that "finishing" treatment is not the end of the journey. In 2024 and 2025, patient advocacy groups began demanding more robust survivorship care plans. The 2026 webinar series represents the culmination of this movement, shifting the focus from merely "surviving" to "thriving."

The scheduling of these webinars in October 2026 coincides with Breast Cancer Awareness Month, intentionally moving the conversation away from just "awareness" of the disease toward "action" for those living in its aftermath.


Supporting Data: The Statistics of the "Afterward"

The need for these educational sessions is underscored by sobering data regarding the long-term health of breast cancer survivors. According to recent Canadian health statistics, there are currently over 250,000 women living in Canada who have been diagnosed with breast cancer in the last 5 to 10 years.

The Physical Burden

  • Lymphedema: Research indicates that between 20% and 30% of breast cancer survivors will develop lymphedema. Without proper education—such as that provided in the "Living Well" session—many patients fail to recognize early symptoms, leading to permanent, debilitating swelling.
  • Post-Mastectomy Pain Syndrome (PMPS): Studies show that 25% to 60% of patients experience chronic pain following breast surgery. This lingering discomfort often goes unaddressed in standard follow-up appointments.
  • Bone Health: Many survivors are placed on hormone-suppressing therapies for 5 to 10 years post-treatment, which can lead to a 2% to 4% annual decrease in bone mineral density, significantly increasing the risk of osteoporosis.

The Psychological Impact

  • Mental Health: A 2025 meta-analysis revealed that nearly 40% of breast cancer survivors report clinical levels of anxiety, and up to 25% suffer from post-traumatic stress disorder (PTSD) related to their medical experiences.
  • Workforce Challenges: Data suggests that approximately 30% of survivors do not return to full-time employment within the first year after treatment, citing physical fatigue and "brain fog" (cognitive impairment) as the primary barriers.
  • The "Care Gap": A survey by Breast Cancer Canada found that while 95% of patients felt well-supported during active treatment, only 18% felt they had a clear roadmap for their health once treatment ended.

Official Responses and Expert Perspectives

The announcement of the webinar series has drawn praise from both the medical community and patient advocacy groups.

Breast Cancer Canada issued a statement emphasizing the importance of specialized knowledge: "We have mastered the science of treating the tumor; now we must master the art of supporting the person. These webinars are designed to fill the void that exists between the oncology clinic and the return to everyday life. We are proud to partner with experts like Voula Pantelis and Jacqueline Beatty who understand that recovery is not a destination, but a continuous process."

Voula Pantelis, representing AMOENA Canada, highlighted the role of body image in recovery: "Physical changes after surgery are not just medical issues; they are identity issues. When a woman looks in the mirror and doesn’t recognize herself, it affects her mental health, her intimacy, and her confidence. Our session is about giving that power back to the survivor through education on scar management and proper prosthetic care."

Jacqueline Beatty, founder of Rising Lotus, spoke to the emotional necessity of the "Root to Rise" framework: "When the ‘war’ is over, survivors are often left standing in the rubble of their old lives. We are told to be ‘grateful’ we survived, but we are also grieving who we used to be. My goal is to provide a framework where survivors can acknowledge that grief, set new boundaries, and rise into a version of themselves that is stronger and more self-aware."


Implications: A New Standard for Post-Cancer Care

The introduction of such detailed survivorship programming suggests a shift in how the healthcare system views long-term recovery. There are several significant implications for the future of oncology:

1. Integration of Rehabilitative Medicine

The "Living Well" session signals a move toward integrating physiotherapy and occupational therapy into standard breast cancer care. By educating survivors on lymphedema and scar management early, the healthcare system can reduce the long-term costs associated with chronic complications and disability claims.

2. Economic and Social Reintegration

By addressing the "transition back to work" in the "Moving Emotions Forward" session, advocates are highlighting the economic impact of cancer. Helping survivors successfully return to the workforce is not just a personal victory; it is a social imperative that maintains the productivity and financial stability of thousands of households.

3. The Redefinition of "Cured"

The series challenges the binary definition of "sick" versus "cured." It acknowledges that a survivor may be "cancer-free" while still requiring significant medical and psychological support. This nuanced understanding is likely to influence future policy, potentially leading to extended insurance coverage for post-operative garments, mental health counseling, and specialized physical therapy.

4. Empowerment Through Information

Perhaps the most significant implication is the democratization of specialized medical knowledge. By providing these webinars free of charge and making the slides publicly available, Breast Cancer Canada is empowering patients to become their own advocates. In an era of "informed patients," these resources provide the data points necessary for survivors to ask their doctors the right questions and demand a higher standard of follow-up care.

Conclusion

As October 2026 approaches, the "Living Well" and "Moving Emotions Forward" webinars stand as a testament to the resilience of the survivor community. By addressing the physical scars and the emotional tremors that follow a cancer diagnosis, Breast Cancer Canada is ensuring that the path forward is paved with more than just hope—it is paved with knowledge, strategy, and a profound sense of community.

Survivors and caregivers are encouraged to register for these sessions and access the shared resources, recognizing that while the treatment of the disease may have ended, the journey toward true wellness is only just beginning.


For more information on registration or to view the slides from the physical effects session, visit breastcancer.ca.

About the Author

Nana

Author

View All Posts

Post navigation

Previous: A Fractured Partnership: Assessing the Fallout of the U.S. Withdrawal from the World Health Organization
Next: A Paradigm Shift in Oncology: Karen and Rob Hale Commit Historic $50 Million to Breast Cancer Research Foundation

Related Stories

navigating-the-nexus-glp-1-medications-and-breast-cancer-a-deep-dive-into-emerging-research-and-patient-concerns
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Emerging Research and Patient Concerns

Layla Zulfa October 17, 2026
global-illumination-over-325-landmarks-to-shine-for-metastatic-breast-cancer-awareness
  • Patient Advocacy and Support

Global Illumination: Over 325 Landmarks to Shine for Metastatic Breast Cancer Awareness

Dwi Wanna October 17, 2026
a-paradigm-shift-in-oncology-karen-and-rob-hale-commit-historic-50-million-to-breast-cancer-research-foundation
  • Patient Advocacy and Support

A Paradigm Shift in Oncology: Karen and Rob Hale Commit Historic $50 Million to Breast Cancer Research Foundation

Ali Ikhwan October 17, 2026

Recent Posts

  • Breakthrough Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth
  • MacroGenics Initiates Phase I Clinical Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors
  • Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Emerging Research and Patient Concerns
  • Global Illumination: Over 325 Landmarks to Shine for Metastatic Breast Cancer Awareness
  • A Paradigm Shift in Oncology: Karen and Rob Hale Commit Historic $50 Million to Breast Cancer Research Foundation

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

breakthrough-research-uncovers-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Breakthrough Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Layla Zulfa October 17, 2026
macrogenics-initiates-phase-i-clinical-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors-1
  • Medical Research and Clinical Trials

MacroGenics Initiates Phase I Clinical Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Reynand Wu October 17, 2026
navigating-the-nexus-glp-1-medications-and-breast-cancer-a-deep-dive-into-emerging-research-and-patient-concerns
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Emerging Research and Patient Concerns

Layla Zulfa October 17, 2026
global-illumination-over-325-landmarks-to-shine-for-metastatic-breast-cancer-awareness
  • Patient Advocacy and Support

Global Illumination: Over 325 Landmarks to Shine for Metastatic Breast Cancer Awareness

Dwi Wanna October 17, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.